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Abstract. Objective: To investigate the possible role of
chromatin texture parameters, nuclear morphology, DNA
ploidy and clinical functional status in discriminating benign
from malignant adrenocortical tumors (ACT). Patients and
Methods: Forty-eight cases of clinically benign (n=40) and
clinically malignant (n=8) ACT with a minimum of 5-years’
follow-up were evaluated for chromatin texture parameters
(run length, standard deviation, configurable run length,
valley, slope, peak and other 21 Markovian features that
describe the distribution of the chromatin in the nucleus),
nuclear morphology (nuclear area, nuclear perimeter,
nuclear maximum and minumum diameter, nuclear shape),
and DNA ploidy. Nuclear parameters were evaluated in
Feulgen-stained 5 μm paraffin-sections analyzed using a
CAS 200 image analyzer. Results: Since ACTs present
different biological features in children and adults, patients
were divided into two groups: children (≤ 15 years) and
adults (>15 years). In the group of children DNA ploidy
presented a marginal significance (p=0.05) in discriminating
ACTs. None of the parameters discriminated between
malignant and benign ACT in the adult group. Conclusion:
ACTs are uncommon and definitive predictive criteria for
malignancy remain uncertain, particularly in children. Our
data point to DNA content evaluated by image analysis as a
new candidate tool for this challenging task. Texture image
analysis did not help to differentiate malignant from benign
adrenal cortical tumors in children and adults.
The distinction between benign and malignant adrenocortical
tumors (ACTs) is often difficult, particularly in children (1-
6)). Although in adult Weiss’ histological score system has
been useful for such distinction (7-10), borderline cases are
still encountered. These indeterminate cases are often small
tumors with several worrisome histological features – a
category of tumor that is becoming more frequently
encountered with the increasing use of noninvasive imaging
techniques such as computerized tomography and magnetic
resonance imaging. 
Quantification in histopathology has the goal of bringing
objectivity to diagnostic assessment and of improving the
diagnostic and prognostic capabilities. The distributive
pattern of chromatin in the cell nuclei is a very sensitive
indicator of changes in cell function and has been used as a
major criterion for diagnosis of malignancy throughout
history, based on visual estimates by conventional optical
microscopy. Chromatin texture by computer-assisted image
analysis has shown distinctive patterns in preneoplastic and
neoplastic lesions of the prostate (10-13), breast (14, 15) and
cervix (16, 17). Only two previous studies have evaluated
chromatin texture parameters in ACT to highlight the
possible role of these kind of parameters in helping to
discriminate benign from malignant ACT (18, 19).
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Materials and Methods
Patients. Forty-eight cases of clinically benign (n=40) and clinically
malignant (n=8) ACT were included in the study. Patients were
submitted to surgical resection of ACT at the Clinical Hospital in
the period between 1979 and 1994, and had a minimum of 5-years’
follow-up. All pertinent clinical information was obtained from
clinical records. Paraffin blocks and pathological reports were
retrieved from the files of the Surgical Pathology Division of the
Clinical Hospital. Metastasis or disease-recurrence was considered
as evidence of malignancy. Patients were divided into two groups:
children (≤15 years) and adults (>15 years) (Table I)
Nuclear parameters. Five μm sections representative of the tumor
in each case were submitted to Feulgen staining and image analysis
using the CAS 200 system (Becton and Dickinson). Briefly, the
slides were placed in 10%  neutral formaldehyde for 30 minutes and
air-dried. Afterwards, hydrolysis was performed with 5 mM HCl for
60 minutes at room temperature. Subsequently, the Thyonin-Feulgen
(Becton and Dickinson) stain was applied, mounted with Entellan
(Merck, Germany) and slides were coverslipped.
Nuclear DNA content analysis was carried out using the CAS 200
system (Becton and Dickinson), provided with quantitative
measurement 3.0 (v. 8.1) (Becton & Dickinson, USA). Optical
density was evaluated for 150 to 200 cells per case using x400 total
magnification. Overlapping images and multinucleated cells were
excluded from the analysis. The system was calibrated with rat
hepatocytes (slide control – Becton and Dickinson) as an external
control. Normal adrenal cortical cells or stromal cells present in the
sample were used as internal diploid reference. According to DNA
histograms, cases were classified as DNA diploid if the DNA index
was in the range of 0.90-1.10; DNA tetraploid, in the range of 1.80-
2.20 and DNA aneuploid in any other situation. 
Chromatin texture parameters were evaluated using Cell View™
(Version 1.0) and Cell Sheet™ (Version 2.0) software (Bacus
Laboratories Inc., Elmhurst, IL, USA); nuclear images were
extracted from Feulgen-stained 5 μm paraffin-sections as
intermediate level maintenance (ILM) files. These nuclei were
analyzed by CAS 200 image analyzer by two of us (RM and AS);
the following features were evaluated for each measured nucleus:
Nuclear area, nuclear perimeter, nuclear maximum diameter, nuclear
minimum diameter and nuclear shape for nuclear morphology; Run
length, standard deviation, configurable run length, valley, slope,
peak and 21 other Markovian features that describe the distribution
of the chromatin in the nucleus. These features derive from the
transition probability matrix that is obtained reducing the optical
density histogram (256 gray levels) of the nucleus into eight gray
levels for the chromatin texture analysis.
Briefly, the meaning of some of these parameters is described
below: Run length: count of the pixels within the nucleus whose gray
level values differ from those of their left and right neighbors;
Configurable run length: similar to run length with the possibility of
configuring the sample size and the difference threshold of the pixel
and the projection of the count; Valley, slope, peak: count of the
pixels within the nucleus that have: two neighboring pixels with
higher gray level values (valley), two neighboring pixels with a
higher and a lower gray level value (slope), two neighboring pixels
with lower gray level values (peak); standard deviation: standard
deviation of optical density of every pixel that composed the nucleus.
Statistical analysis. Mean values of chromatin texture features and
nuclear area were compared in clinically benign and malignant
tumors using the Mann-Whitney U-test. Functional status and DNA
ploidy category were compared in benign and malignant tumors
using Fisher’s exact test. A difference was considered significant
when the type I error was less than 0.05.
Results
The group of patients comprised 18 children and 30 adults.
The gender distribution and mean age are shown in Table I.
Results for area and chromatin texture analysis and
biological behavior of the tumor in children are presented in
Table II; the non-parametric Mann-Whitney test did not
show any significant results. A similar analysis for adults is
presented in Table III but again no significant result was
observed. Table IV shows the evaluation of DNA ploidy as
related to the biological behavior of the tumors in children
and adults. Fischer’s exact test showed marginal significance
(p=0.05) in the children’s group, but not in that of the adults. 
Among all parameters, in the group of children only DNA
ploidy presented a marginal statistical significance (p=0.05).
None of the parameters studied discriminated between
benign and malignant ACT in the adult group. 
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Table I. Group of patients.
Tumor biological  Gender Age (years)
behavior
Benign Malignant Male Female Mean Range 
Children 15 3 4 14 3.7 0.6-15
Adults 25 5 4 26 33.4 19-53
Table II. Area and chromatin texture parameters and biological behavior
of tumors in children. 
Parameter Biological Mean Sum of P-value*
behavior rank ranks
Area Benign 9.93 149 0.49
Malignant 7.33 22
Run length Benign 10.33 155 0.16
Malignant 5.33 16
Cfg. run length Benign 10.0 150 0.42
Malignant 7.0 21
Valley Benign 10.33 155 0.16
Malignant 5.33 16
Slope Benign 10.4 156 0.13
Malignant 5.0 15
Peak Benign 9.13 137 0.57
Malignant 11.33 34
Cfg., Configurable. *Mann-Whitney test; benign=15; malignant=3.
Discussion
ACTs are uncommon. In the USA, only about 25 new cases
occur each year and constitute only about 0.2%  of all
pediatric malignancies. However, the incidence of ACT
varies across geographical regions and is remarkably high in
southern Brazil, particularly in children, where it is 10-15
times higher than that of pediatric ACT worldwide (20, 21). 
The most important point to be defined in a patient with
an ACT is the differential diagnosis between adenoma and
carcinoma. There is no single histological criterion which can
reasonably differentiate adrenocortical carcinoma from
adenoma such as capsular or vascular invasion in thyroid
follicular carcinoma. Among various criteria used, the criteria
proposed by Weiss (7, 8), which evaluate nine histological
features of the tumor most frequently associated with poor
clinical outcome of the patients, have been most widely
employed due to the straightforwardness of the criteria and
easy applicability. In previous reports (2, 3, 5, 6, 9), the Weiss
score system is reliable and easily used in routine practice
and is a good predictor of clinical behavior in adults with
ACT. However, this is not the case in children, where most
cases classified as adrenocortical carcinoma by these criteria
will present a benign clinical course. Recently, molecular and
cellular features of ACT have been studied (22), but the
relatively low frequency of this disease, the lack of a well
established pre-malignant condition in human adrenal cortex
and the marked heterogeneity in morphology and biological
function have contributed to the lack of definitive conclusions
helpful to this practical and important issue. 
Cellular features such as chromatin texture, nuclear
morphology and DNA content analysis have been studied by
different groups in ACT in both children and adults. Scarpelli
et al. (18, 19) described different findings regarding nuclear
size, chromatin pattern and DNA content in 10
adrenocortical adenomas and 5 adrenocortical carcinomas,
analyzed by image analysis. As far as we know, no other data
regarding chromatin texture in ACT have been published. 
Regarding DNA ploidy, Zerbini et al. (2) and Bugg et al.
(23) did not find a statistically significant difference in DNA
ploidy evaluated by image analysis in a series exclusively of
pediatric patients. Other series, including children and adults
together, demonstrated positive (24, 25) or negative (26)
correlation between ploidy and malignancy defined by
pathology or clinical behavior. Controversial results have been
attributed to four important considerations: first, ACTs in
children differ significantly from similar neoplasms in adults
and must be evaluated separately; second, different methods,
including image analysis and flow cytometry, used especially
for DNA content analysis may have technical differences to be
considered before comparison of results can be made; third,
because of the rarity of these tumors, the number of cases is
generally small, and lastly, ideally, every study should have as
an endpoint the clinical behavior, defined by the occurrence of
recurrent or metastatic disease, especially in the pediatric age
group. Interestingly, in this series, DNA non-diploid tumors
were associated with benign neoplasms in children (see Table
IV), as usually occurs with other types of pediatric cancer such
as neuroblastoma (27) and acute lymphoblastic leukemia (28).
These findings did not show a statistically significant
correlation of the chromatin texture parameters, but did
demonstrate a marginally significant correlation of DNA
ploidy with clinical behavior in children, suggesting that this
feature should be added to morphological parameters
recently defined in pediatric ACT (4) for validation in larger
series collected by the International Pediatric Adrenocortical
Tumor Registry (29). 
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Table III. Area and chromatin texture parameters and biological
behavior of tumors in adults.
Parameters Biological behavior Mean P-value*
Area Benign 14.88 0.41
Malignant 18.60
Run length Benign 15.04 0.55
Malignant 17.80
Cfg. run length Benign 15.04 0.55
Malignant 17.80
Valley Benign 14.72 0.30
Malignant 19.40
Slope Benign 14.64 0.25
Malignant 19.80
Peak Benign 16.28 0.30
Malignant 11.60
Cfg., Configurable. *Mann-Whitney test; benign=25; malignant=5
Table IV. DNA ploidy and biological behavior in tumors from children
and adults.
DNA ploidy Benign Malignant Total P-value*
Children
Diploid 33.33% 66.7% 100%
Aneuploid + tetraploid 100% 100% 0.05
Total 81.8% 18.2% 100%
Adults
Diploid 83.3% 16.7% 100%
Aneuploi + tetraploid 80.0% 20% 100% 0.61
Total 81.5% 18.5% 100%
*Fischer’s exact test.
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